AquaBounty Technologies (NASDAQ:AQB) Issues Quarterly Earnings Results, Beats Estimates By $1.07 EPS

AquaBounty Technologies (NASDAQ:AQB – Get Free Report) issued its earnings results on Friday. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($1.30) by $1.07, Zacks reports.

AquaBounty Technologies Price Performance

Shares of NASDAQ AQB opened at $0.98 on Friday. The firm has a fifty day moving average price of $1.08 and a 200-day moving average price of $1.02. AquaBounty Technologies has a 1 year low of $0.77 and a 1 year high of $1.64. The stock has a market cap of $5.10 million, a PE ratio of -1.19 and a beta of 1.45.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, September 14th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, AquaBounty Technologies has a consensus rating of “Sell”.

Get Our Latest Analysis on AQB

About AquaBounty Technologies

(Get Free Report)

AquaBounty Technologies, Inc is a biotechnology and aquaculture company focused on developing and producing land-raised Atlantic salmon. Its principal product is AquAdvantage salmon, a genetically engineered salmon designed to reach market size more quickly than conventional Atlantic salmon. The company has pursued land-based, contained aquaculture systems intended to reduce reliance on ocean-based farming and improve production efficiency.

AquAdvantage salmon incorporates a growth-hormone gene from Chinook salmon and a regulatory sequence from ocean pout.

Read More

Earnings History for AquaBounty Technologies (NASDAQ:AQB)

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.